FDA Approves Genentech's Zelboraf, the First-Ever Drug to Treat Specific Rare Blood Disease

  • Post author:
  • Post category:BioPharma

People diagnosed with the rare blood disorder known as Erdheim-Chester disease have a new treatment option.
Source: BioSpace